These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International Registry. Brenner EJ; Ungaro RC; Gearry RB; Kaplan GG; Kissous-Hunt M; Lewis JD; Ng SC; Rahier JF; Reinisch W; Ruemmele FM; Steinwurz F; Underwood FE; Zhang X; Colombel JF; Kappelman MD Gastroenterology; 2020 Aug; 159(2):481-491.e3. PubMed ID: 32425234 [TBL] [Abstract][Full Text] [Related]
10. Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis: Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR). Kalb RE; Fiorentino DF; Lebwohl MG; Toole J; Poulin Y; Cohen AD; Goyal K; Fakharzadeh S; Calabro S; Chevrier M; Langholff W; You Y; Leonardi CL JAMA Dermatol; 2015 Sep; 151(9):961-9. PubMed ID: 25970800 [TBL] [Abstract][Full Text] [Related]
11. Prevalence, risk and severity of SARS-CoV-2 infections in psoriasis patients receiving conventional systemic, biologic or topical treatment during the COVID-19 pandemic: a cross-sectional cohort study (PsoCOVID). Kwee KV; Murk JL; Yin Q; Visch MB; Davidson L; de Jong EMGJ; van den Reek JMPA; Tjioe M J Dermatolog Treat; 2023 Dec; 34(1):2161297. PubMed ID: 36545844 [TBL] [Abstract][Full Text] [Related]
12. Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry. Gianfrancesco MA; Leykina LA; Izadi Z; Taylor T; Sparks JA; Harrison C; Trupin L; Rush S; Schmajuk G; Katz P; Jacobsohn L; Hsu TY; D'Silva KM; Serling-Boyd N; Wallwork R; Todd DJ; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Machado PM; Robinson PC; Yazdany J; Arthritis Rheumatol; 2021 Mar; 73(3):374-380. PubMed ID: 33146001 [TBL] [Abstract][Full Text] [Related]
13. Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR). Strober B; Gooderham M; de Jong EMGJ; Kimball AB; Langley RG; Lakdawala N; Goyal K; Lawson F; Langholff W; Hopkins L; Fakharzadeh S; Srivastava B; Menter A J Am Acad Dermatol; 2018 Jan; 78(1):70-80. PubMed ID: 29102053 [TBL] [Abstract][Full Text] [Related]
14. Factors associated with the severity of COVID-19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID-19 Registry. Pizzamiglio C; Pitceathly RDS; Lunn MP; Brady S; De Marchi F; Galan L; Heckmann JM; Horga A; Molnar MJ; Oliveira ASB; Pinto WBVR; Primiano G; Santos E; Schoser B; Servidei S; Sgobbi Souza PV; Venugopalan V; Hanna MG; Dimachkie MM; Machado PM; Eur J Neurol; 2023 Feb; 30(2):399-412. PubMed ID: 36303290 [TBL] [Abstract][Full Text] [Related]
15. Nineteen months into the pandemic, what have we learned about COVID-19-related outcomes in patients with psoriasis? Kridin K; Schonmann Y; Onn E; Bitan DT; Weinstein O; Shavit E; Cohen AD J Cosmet Dermatol; 2022 Dec; 21(12):6549-6553. PubMed ID: 36056782 [TBL] [Abstract][Full Text] [Related]
16. A systematic review and meta-analysis of investigating the mutual impact of COVID-19 and psoriasis: Focusing on COVID-19 course in psoriasis and the opinion on biologics in this setting. Ghoreishi Amin N; Khosravi S; Atefi N; Seirafianpour F; Farhoodi S; Goodarzi A Immun Inflamm Dis; 2023 Nov; 11(11):e1063. PubMed ID: 38018599 [TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Severe Outcomes in Patients With Systemic Vasculitis and COVID-19: A Binational, Registry-Based Cohort Study. Rutherford MA; Scott J; Karabayas M; Antonelou M; Gopaluni S; Gray D; Barrett J; Brix SR; Dhaun N; McAdoo SP; Smith RM; Geddes CC; Jayne D; Luqmani R; Salama AD; Little MA; Basu N; Arthritis Rheumatol; 2021 Sep; 73(9):1713-1719. PubMed ID: 33750043 [TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and outcomes of psoriasis patients with COVID-19: A retrospective, multicenter cohort study in China. Liu Y; Xu Z; Zhou J; Chen A; Zhang J; Kang X; Jiang X; Lyu C; Shi C; Shi Y; Liu X; Li F; Yang B; Huang Y; Yu C; Wang G Chin Med J (Engl); 2024 Jul; 137(14):1736-1743. PubMed ID: 38710539 [TBL] [Abstract][Full Text] [Related]
19. Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials. Garcia-Doval I; Carretero G; Vanaclocha F; Ferrandiz C; Daudén E; Sánchez-Carazo JL; Alsina M; Herrera-Ceballos E; Gómez-García FJ; Ferrán M; López-Estebaranz JL; Hernanz JM; Belinchón-Romero I; Vilar-Alejo J; Rivera R; Carrascosa JM; Carazo C Arch Dermatol; 2012 Apr; 148(4):463-70. PubMed ID: 22508869 [TBL] [Abstract][Full Text] [Related]
20. Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. Hendren NS; de Lemos JA; Ayers C; Das SR; Rao A; Carter S; Rosenblatt A; Walchok J; Omar W; Khera R; Hegde AA; Drazner MH; Neeland IJ; Grodin JL Circulation; 2021 Jan; 143(2):135-144. PubMed ID: 33200947 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]